Spain’s PharmaMar says COVID-19 treatment shows clinical efficacy in trials
Spain’s PharmaMar said on Wednesday its first trials of its Aplidin drug on hospitalised patients with moderate COVID-19 showed clinical effects and met safety standards. The results of these first…
